Daily briefing: Good news for Moderna's two-in-one COVID and flu vaccine
Briefly

Plans for a US$17 billion European particle accelerator, the Future Circular Collider (FCC), face funding challenges as the German government questions its affordability, citing a vague financing plan and uncertain external partnerships.
The FBI addresses concerns of discrimination against researchers of Asian descent under the now-defunct China Initiative, with ongoing scrutiny leading to deportations of Chinese students, highlighting the need for continued efforts to build trust.
Researchers identify a genetic driver for immune disorders in a 'gene desert,' revealing a section of DNA linking to inflammation by enhancing the ETS2 gene's activity, offering insights into diseases like inflammatory bowel disease and ankylosing spondylitis.
Read at Nature
[
|
]